Streetbeat News

Regulatory

MCHI

MYND

iHuman Inc. (NYSE: IH) reported a decline in revenue and profit for Q1, with a notable omission of its latest paid user count, suggesting a continued decline. The company is focusing on global expansion to mitigate risks from China's regulatory environment. Despite some positive metrics like increased MAUs and improved gross margin, the stock fell 4.3% post-earnings and has underperformed compared to the broader rally in U.S.-listed Chinese shares.

Portfolio Pulse from The Bamboo Works

July 03, 2024 | 3:18 pm

ASML

ASML Holding N.V. (NASDAQ:ASML) shares are trading higher following a court ruling that allows the company to proceed with its expansion plans at its headquarters in Veldhoven, Netherlands. The court dismissed objections from neighbors regarding traffic and noise concerns, supporting the approval granted by Veldhoven’s town council in 2022. The expansion aims to support ASML’s growth and includes a larger project in Eindhoven to accommodate 20,000 new employees by 2030.

Portfolio Pulse from Shivani Kumaresan

July 03, 2024 | 3:13 pm

LLY

NVO

A new study from Massachusetts Eye and Ear has found a potential link between semaglutide, the active ingredient in Ozempic and Wegovy, and a serious eye condition called nonarteritic anterior ischemic optic neuropathy (NAION). The study indicates that diabetics on semaglutide have a four times higher risk of developing NAION, while those taking the drug for weight loss have a seven times higher risk. The findings were published in JAMA Ophthalmology.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:03 pm

SPY

The White House has denied a New York Times story about President Biden, calling it 'absolutely false.'

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 3:01 pm

DIA

GLD

QQQ

SPY

TLT

UUP

The US services sector experienced its largest contraction in over four years, with the ISM Services PMI falling to 48.8% in June. This contraction led to a mixed market reaction: stocks held gains, bond yields fell, and the dollar weakened as traders anticipated potential Fed rate cuts. Key ETFs like SPY, QQQ, DIA, TLT, UUP, and GLD were impacted.

Portfolio Pulse from Piero Cingari

July 03, 2024 | 2:35 pm

ICU

SeaStar Medical (NASDAQ:ICU) shares are trading higher after the FDA approved the final labeling for QUELIMMUNE, a treatment for children with acute kidney injury and sepsis. The company plans to start shipping this month and is also conducting trials with adults.

Portfolio Pulse from Dylan Berman

July 03, 2024 | 2:29 pm

GLD

SLV

Gold and silver prices are rising due to a weaker dollar and softer-than-expected employment data, which may influence Federal Reserve policy.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 2:17 pm

TSLA

The U.S. Supreme Court will hear an appeal from the adult entertainment industry challenging a Texas law mandating age verification for pornographic websites. The law, signed by Texas Governor Greg Abbott, imposes significant penalties for non-compliance. The case will be reviewed in the fall.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 2:08 pm

ETHUSD

SOLUSD

VANEX

Matthew Sigel, VanEck’s Head of Digital Assets Research, stated that cryptocurrency voters could influence the upcoming U.S. presidential election. He noted a shift in the regulatory environment with more Democrats supporting pro-crypto legislation. Sigel emphasized the importance of regulatory treatment of Ethereum and Solana, and criticized SEC Chair Gary Gensler's approach. He expressed optimism for the approval of digital asset ETFs with a slight regulatory shift.

Portfolio Pulse from Murtuza Merchant

July 03, 2024 | 1:57 pm

SCNI

Scinai Immunotherapeutics has received approval from Nasdaq to continue its listing, provided it meets the equity requirement by August 14, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:35 pm